ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,460Medicare Part D Prescriptions Filled, Including Refills

Rank: 75 out of 3001

$1.27M Total Retail Price of All Prescriptions

Rank: 59 out of 3001

534 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 534 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 534 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 9,543 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 662 304 1 3
SIMVASTATIN 508 315 2 1
OMEPRAZOLE 471 234 3 4
FUROSEMIDE 413 252 4 6
POTASSIUM CHLORIDE 388 269 5 15
METOPROLOL TARTRATE 372 197 6 8
METFORMIN HCL 342 194 7 9
LISINOPRIL 300 195 8 2
SERTRALINE HCL 275 108 9 20
LACTULOSE 263 102 10 116
CITALOPRAM HBR 256 112 11 16
ALLOPURINOL 250 109 12 35
JANTOVEN 229 73 13 110
WARFARIN SODIUM 214 122 14 12
HYDROCODONE-ACETAMINOPHEN 214 68 S3 14 7
LANTUS 204 76 16 47
NEXIUM 203 102 17 23
AMLODIPINE BESYLATE 195 152 18 5
ATORVASTATIN CALCIUM 193 100 19 11
TRIAMTERENE-HCTZ 192 91 20 48
RANITIDINE HCL 179 70 21 41
AZITHROMYCIN 173 83 22 36
SPIRONOLACTONE 158 69 23 75
PROAIR HFA 155 68 24 30
DIGOXIN 151 102 25 65
GABAPENTIN 150 53 26 14
RENVELA 148 64 27 409
CARVEDILOL 144 84 28 25
ATENOLOL 141 109 29 18
TRAMADOL HCL 139 73 30 17
QUETIAPINE FUMARATE 136 84 31 66
SPIRIVA 136 82 31 57
CRESTOR 135 32 33 33
CELEBREX 134 68 34 89
NASONEX 133 16 35 294
PAROXETINE HCL 131 52 36 60
IBANDRONATE SODIUM 128 58 37 369
DONEPEZIL HCL 127 97 38 27
CYCLOBENZAPRINE HCL 126 46 R 39 73
CIPROFLOXACIN HCL 125 84 40 56
RISPERIDONE 125 36 40 63
TRICOR 120 26 42 132
ADVAIR DISKUS 119 40 43 58
CLOPIDOGREL 115 71 44 28
IBUPROFEN 109 57 45 74
DIVALPROEX SODIUM ER 107 0 46 142
MIRTAZAPINE 104 80 47 44
FAMOTIDINE 99 47 48 68
OLANZAPINE 98 66 49 106
PHENYTOIN SODIUM EXTENDED 97 40 50 126
ABILIFY 96 15 51 144
PLAVIX 94 54 52 46
BONIVA 93 34 53 475
ESCITALOPRAM OXALATE 93 34 53 82
LABETALOL HCL 92 53 55 189
LIPITOR 92 47 55 100
MUPIROCIN 90 42 57 180
CLOZAPINE 87 23 58 170
METOPROLOL SUCCINATE 87 61 58 19
CYMBALTA 87 33 58 53
NAMENDA 86 64 61 40
AMOX TR-POTASSIUM CLAVULANATE 86 39 61 143
BUMETANIDE 86 36 61 151
VENLAFAXINE HCL ER 85 17 64 103
DIOVAN HCT 84 38 65 109
METOCLOPRAMIDE HCL 81 41 66 139
PREDNISONE 81 53 66 39
JANUVIA 80 61 68 54
GLYBURIDE 80 34 R 68 62
PANTOPRAZOLE SODIUM 80 52 68 43
NYSTATIN-TRIAMCINOLONE 80 61 68 248
TOVIAZ 80 30 68 485
FLUTICASONE PROPIONATE 78 34 73 42
DOXYCYCLINE HYCLATE 77 33 74 105
CALCIUM ACETATE 74 44 75 419
BUSPIRONE HCL 74 34 75 91
FENTANYL 74 43 S2 75 76
OXYBUTYNIN CHLORIDE 71 29 78 120
MELOXICAM 71 35 78 34
TOPIRAMATE 71 0 78 156
DIOVAN 70 23 81 50
ALBUTEROL SULFATE 69 51 82 99
NYSTATIN 69 60 82 149
SINGULAIR 69 18 82 95
SODIUM CHLORIDE 67 43 85 199
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 52 85 22
IPRATROPIUM-ALBUTEROL 67 34 85 119
SUCRALFATE 65 14 88 164
POLYETHYLENE GLYCOL 3350 64 20 89 55
SEROQUEL 63 26 90 146
LORAZEPAM 61 33 91 96
LYRICA 60 0 92 87
ENDOCET 60 27 S2 92 165
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 13 92 77
MEGESTROL ACETATE 59 50 R 95 200
ENALAPRIL MALEATE 57 27 96 83
FLUOXETINE HCL 57 31 96 61
BACLOFEN 57 0 96 125
ZOLPIDEM TARTRATE 56 32 99 24
CLOTRIMAZOLE-BETAMETHASONE 56 32 99 181
GLIPIZIDE 56 42 99 67
COMBIVENT 55 0 102 184
LEVEMIR 54 0 103 204
BUPROPION XL 54 0 103 176
AMLODIPINE BESYLATE-BENAZEPRIL 54 27 103 78
CARBAMAZEPINE 53 0 106 134
NITROFURANTOIN MONO-MACRO 53 35 106 158
LEVETIRACETAM 52 29 108 112
NYSTOP 52 34 108 167
ISOSORBIDE MONONITRATE ER 52 42 108 45
FENOFIBRATE 52 33 108 59
TAMSULOSIN HCL 52 49 108 29
CEFTRIAXONE 52 23 108 209
TRIAMCINOLONE ACETONIDE 50 16 114 159
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.